Back

NSTE-ACS and complex angioplasty: a lost opportunity if potent P2Y12 inhibitors are not available everywhere in Algeria - discussion of guideline implementation

28 August 2023 (12:45 - 13:00)
Organised by: Logo
Congress Presentation Part of: A large country and a very high cardiovascular risk: how to apply NSTE-ACS ESC Guidelines in Algeria Acute Coronary Syndromes ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

3 More presentations in this session

Presentation thumbnail
Case 1: invasive strategy for NSTE-ACS in Algeria - better late than never!
Professor N. Laredj (Oran, DZ)
Slides Video
Presentation thumbnail
Invasive strategy for NSTE-ACS in Algeria: better late than never! - discussion of guideline implementation
Video
Presentation thumbnail
Case 2: NSTE-ACS and complex angioplasty - a lost opportunity if potent P2Y12 inhibitors are not available everywhere in Algeria
Associate Professor Y. Bououdina (Algiers, DZ)
Slides Video

Access the full session

Session thumbnail
A large country and a very high cardiovascular risk: how to apply NSTE-ACS ESC Guidelines in Algeria
Video

The Event

Event poster

ESC Congress 2023

28 August 2023 12:45 CET
You may be interested in
thumbnail
Congress Presentation
Case 2: NSTE-ACS and complex angioplasty - a lost opportunity if potent P2Y12 inhibitors are not available everywhere in Algeria
thumbnail
Congress Session
A large country and a very high cardiovascular risk: how to apply NSTE-ACS ESC Guidelines in Algeria
thumbnail
Congress Session
Implementation in real-world practice of ESC Guidelines for the acute management of patients with NSTE-ACS

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources